{"disease":{"id":"control-arm-in-phase-3-trials-for-fenebrutinib-targeted-indications-likely-autoimmune-inflammatory-conditions","name":"control arm in phase 3 trials for fenebrutinib targeted indications likely autoimmune inflammatory conditions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}